Introduction Rheumatoid arthritis (RA) is a complex autoimmune disease that affects millions
of people worldwide, with a systemic impact. This review explores the role of non-biological …

Rheumatoid arthritis (RA) and periodontal disease (PD) are chronic complex inflammatory
diseases with several common susceptibility factors, especially genetic and environmental …

Objectives To investigate the impact of disease activity and treatment with disease-modifying
antirheumatic drugs (DMARDs) on all-cause mortality in patients with rheumatoid arthritis …

Objective To provide the initial installment of a living guideline that will provide up-to-date
guidance on the pharmacological management of patients with rheumatoid arthritis (RA) in …

Disease-modifying anti-rheumatic drugs (DMARDs) is a class of anti-rheumatic medicines
that are frequently prescribed to patients suffering from rheumatoid arthritis (RA) …

Background The COVID-19 pandemic has had an unprecedented impact in the global
research production and has also increased research waste. Living evidence syntheses …

Objective More than ever, it is important to consider inclusion and diversity in rheumatology
research. We reviewed and synthesized randomized controlled trials (RCTs) for rheumatoid …

Objectives To understand trainee experiences of participating in a living systematic review
(LSR) for rheumatoid arthritis and the potential benefits in terms of experiential evidence …

In the last few years there has been an increased appreciation that pain perception in
rheumatic and musculoskeletal diseases (RMDs) has several mechanisms which include …

Objectives To evaluate an approach using automation and crowdsourcing to identify and
classify randomized controlled trials (RCTs) for rheumatoid arthritis (RA) in a living …